Figure 6.

Protective effect of allicin on PI3K/Akt protein and phosphorylation levels in TSCI mice. (A) The effects of allicin on the PI3K/Akt and p-Akt levels were measured using western blotting. (B) Analysis of PI3K levels and (C) p-Akt/Akt in samples from the sham, TSCI model and allicin-treated (1, 5 or 10 mg/kg) groups. Data are presented as the mean ± standard error. ^**P<0.01 vs. sham group, ^##P<0.01 vs. TSCI model group. TSCI, traumatic spinal cord injury; PI3K, phosphatidylinositol-4,5-bisphosphate 3-kinase; Akt, v-akt murine thymoma viral oncogene homolog 1; p-Akt, phospho-Akt.